Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deals Of The Week: Janssen/CorImmun, AstraZeneca/Cellworks, Ferring/Albireo

Executive Summary

To the familiar sounds of the Fourth of July and mid-summer, Deals of the Week adds another: the sound of the next shoe dropping in biopharmaceutical merger-and-acquisition activity. What happens next after the $5 billion-plus buyout of Amylin by Bristol-Myers?

Advertisement

Related Content

Deals Of The Week: Academic Drug-Discovery Group’s Work Catching Industry’s Notice
AZ’s MedImmune Buys Spirogen To Boost Oncology ADC Capability
Deals Of The Week Gets Better Connected, Dips A Toe In Digital Health
With Bristol/AstraZeneca In Driver’s Seat, GLP-1 Race Takes A Turn
Belviq Gains FDA Approval For Weight Loss, But DEA Review Will Delay Launch
AstraZeneca Shifts Abandoned GI Developmental Compounds To New Affiliate

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS054568

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel